Use of Topical 2.4% Glycopyrronium Tosylate in Familial Benign Pemphigus (Hailey-Hailey Disease)

Authors

Richard Bindernagel, Kansas City UniversityFollow
Brooks D. Kimmis, University of Kansas Medical Center
Deede Liu, University of Kansas Medical Center

Document Type

Letter to the Editor

Publication Title

Dermatology Online Journal

DOI

10.5070/D32610050474

Publication Date

10-2020

Keywords

genodermatoses, general medical dermatology, pharmacology

ISSN

1087-2108

Recommended Citation

Bindernagel R, Kimmis BD, Liu D. Use of Topical 2.4% Glycopyrronium Tosylate in Familial Benign Pemphigus (Hailey-Hailey Disease). Dermatology Online Journal. 2020; 26(10). doi: 10.5070/D32610050474.